Zacks.com featured highlights include General Motors, Expedia Group, Phibro Animal Health and Pilgrim's Pride
Werte in diesem Artikel
For Immediate ReleaseChicago, IL – February 18, 2025 – Stocks in this week’s article are General Motors GM, Expedia Group EXPE, Phibro Animal Health PAHC and Pilgrim's Pride PPC.4 PEG-Based Value Stocks to Shield Your Portfolio from Trade WarThe equity markets in 2025 have been marked by intense volatility, largely driven by geopolitical tensions and renewed trade conflicts. Trump's aggressive tariff policies have escalated trade disputes with major economies, particularly China and the European Union, leading to retaliatory measures. This has disrupted global supply chains, increased production costs and ultimately dampened investor confidence.Adding to the market unease, the Federal Reserve's recent decision to maintain interest rates at current levels has thwarted expectations. Many investors had anticipated rate cuts to counterbalance economic pressure from trade disruptions and geopolitical risks. The Fed's cautious stance suggests that it is prioritizing inflation control over short-term market stability, leaving investors uncertain about future monetary policy direction.Periods of heightened volatility often trigger shifts in investor behavior. With growing macroeconomic uncertainties, many investors are re-evaluating their portfolio strategies. Historically, it has been seen that in times of volatility, investors tend to choose value investing over other options like growth or momentum. As soon as other investors start selling their stocks at a cheaper rate in times of market uncertainty, value investors take this as an opportunity to pick good stocks at a discounted price.Several stocks that have surged significantly in recent times have shown the overwhelming success of this pure-play investment strategy. Here, we discuss four such stocks: General Motors, Expedia Group, Phibro Animal Health and Pilgrim's Pride.Earnings Growth Potential Crucial to Avoid Value TrapsSimple value investing, if not executed with proper diligence, can lead to value traps. A stock may appear undervalued based on traditional metrics like the price-to-earnings (P/E) ratio or price-to-book (P/B) ratio. But if the underlying business is deteriorating rather than temporarily struggling, the investment may turn out to be a poor choice.For investors looking to escape such value traps, it is vital to determine where the stock will be headed in the next 12 to 24 months. Warren Buffett advises them to focus on the earnings growth potential of a stock. This is where the importance of a not-so-popular value investing metric, the PEG ratio, lies.PEG Ratio at a GlanceThe PEG ratio is defined as (Price/ Earnings)/Earnings Growth RateA low PEG ratio is always better for value investors.While P/E alone fails to identify a true value stock, PEG helps find the intrinsic value of a stock.There are some drawbacks to using the PEG ratio. It does not consider the common situation of changing growth rates, such as the forecast of the first three years at a very high growth rate, followed by a sustainable but lower growth rate over the long term.Hence, PEG-based investing can turn out to be even more rewarding if some other relevant parameters are also taken into consideration.Here are four out of the 11 stocks that qualified the screening:General Motors: The company, along with its strategic partners, produces, sells and services cars, trucks and parts under four core brands — Chevrolet, Buick, GMC and Cadillac. General Motors assembles passenger cars, crossover vehicles, light trucks, sport utility vehicles, vans and other vehicles.GM currently has a Zacks Rank #2 and a Value Score of A. General Motors also has an impressive five-year historical growth rate of 14.2%.Expedia: Bellevue, Washington-based Expedia Group is one of the largest online travel companies in the world. Expedia's strong brand portfolio, comprising Brand Expedia, Hotels.com, Vrbo, Orbitz, Travelocity, ebookers and Wotif Group, to name a few, offers a full range of travel and advertising services to travelers, suppliers and business partners.Apart from a discounted PEG and P/E, Exelixis currently has a Zacks Rank #2 and a Value Score of B. EXPE has a long-term expected growth rate of 18.2%.Phibro: This global diversified animal health and mineral nutrition company provides a broad range of products for food animals, including poultry, swine, beef, dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries.Phibro has a Zacks Rank #1 and a Value Score of A. PAHC also has an impressive five-year expected growth rate of 26.2%.Pilgrim's Pride: This Greeley, CO-based company is engaged in the processing, production, marketing and distribution of frozen, fresh as well as value-added chicken products. The company offers its services in the United States, Mexico, France, the Netherlands, Puerto Rico and Mexico through a number of distributors, retailers and food service operators.Apart from a discounted PEG and P/E, PPC currently sports a Zacks Rank #1 and has a Value Score of A. Pilgrim's Pride has a long-term expected growth rate of 48.2%. You can see the complete list of today's Zacks #1 Rank stocks here.You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial to the Research Wizard todayFor the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2416322/4-peg-based-value-stocks-to-shield-your-portfolio-from-trade-warDisclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.About Screen of the WeekZacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.Strong Stocks that Should Be in the NewsMany are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.Follow us on Twitter: https://www.twitter.com/zacksresearchJoin us on Facebook: https://www.facebook.com/ZacksInvestmentResearchZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Expedia Group, Inc. (EXPE): Free Stock Analysis Report General Motors Company (GM): Free Stock Analysis Report Pilgrim's Pride Corporation (PPC): Free Stock Analysis Report Phibro Animal Health Corporation (PAHC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Expedia und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Expedia
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Expedia
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Expedia Inc.
Analysen zu Expedia Inc.
Datum | Rating | Analyst | |
---|---|---|---|
16.07.2019 | Expedia Buy | Standpoint Research | |
21.05.2019 | Expedia Hold | Needham & Company, LLC | |
08.02.2019 | Expedia Buy | Needham & Company, LLC | |
08.02.2019 | Expedia Market Perform | Telsey Advisory Group | |
29.11.2018 | Expedia Market Perform | Telsey Advisory Group |
Datum | Rating | Analyst | |
---|---|---|---|
16.07.2019 | Expedia Buy | Standpoint Research | |
08.02.2019 | Expedia Buy | Needham & Company, LLC | |
08.02.2019 | Expedia Market Perform | Telsey Advisory Group | |
29.11.2018 | Expedia Market Perform | Telsey Advisory Group | |
26.10.2018 | Expedia Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
21.05.2019 | Expedia Hold | Needham & Company, LLC | |
09.02.2018 | Expedia Hold | The Benchmark Company | |
31.03.2016 | Expedia Sector Weight | Pacific Crest Securities Inc. | |
01.05.2015 | Expedia Hold | Deutsche Bank AG | |
13.02.2015 | Expedia Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
28.10.2016 | Expedia Sell | Stifel, Nicolaus & Co., Inc. | |
07.02.2008 | Expedia Downgrade | Morgan Stanley | |
24.02.2006 | Expedia Bär der Woche | Der Aktionärsbrief | |
10.02.2006 | Expedia Downgrade | Crédit Suisse | |
09.09.2005 | Update Expedia Inc.: Underperform | Goldman Sachs |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Expedia Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen